1606 CORP.
0.0010+0.00 (+0%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · CBDW · USD
Key Stats
Market Cap
169.73KP/E (TTM)
-Basic EPS (TTM)
-0.05Dividend Yield
0%Recent Filings
8-K
Note amended, principal rises
1606 Corp. amended its promissory note to former CEO Gregory Lambrecht on October 21, 2025, boosting the principal to $1,829,550 from prior loans. The note now allows conversion of all principal and interest into common stock at a 25% discount to the closing bid price, capped by a 4.99% ownership limit. This bolsters liquidity for the emerging growth company. Yet risks linger if conversion floods shares.
8-K
Attending NIBA for M&A
1606 Corp. announced its attendance at the 151st NIBA Conference in Fort Lauderdale on September 16, 2025, to network with investment professionals and explore M&A opportunities aligning with its AI chatbot growth strategy. CEO Austen Lambrecht highlighted potential partnerships to accelerate uplisting to Nasdaq or NYSE and boost shareholder value, while the team has scheduled numerous meetings. Yet risks like funding needs and competition loom large.
8-K
Timely 10-Q filing announced
1606 Corp. filed its Q2 2025 10-Q on August 13, 2025, underscoring its dedication to SEC compliance since inception. Trading volume has surged since the July 1 OTCID transition, signaling growing investor interest. The company is actively scouting M&A deals to boost market reach and capabilities. Yet risks like funding needs loom large.
8-K
Note amended, principal rises
1606 Corp. amended its promissory note to former CEO Gregory Lambrecht on August 6, 2025, boosting the principal to $1,739,550 from $1,528,550 due to fresh loans. The note now allows conversion of all principal and interest into common stock at a 25% discount to the closing bid price, capped by a 4.99% ownership limit. This bolsters short-term liquidity but dilutes equity if converted. Debt grows amid funding needs.
10-Q
Q2 FY2025 results
1606 Corp. posted no revenue for Q2 FY2025 ended June 30, 2025, mirroring last year but down from $7,195 in H1 2024, while operating expenses fell sharply to $117,084 from $288,739 y/y, trimming the operating loss to $117,084. Net loss narrowed to $210,111 from $339,192 y/y, though it widened q/q from $208,339 (derived), with the gap to operating loss driven by interest expense and adverse fair-value changes in derivative liabilities. Cash dwindled to $1,863 amid $276,685 in operating outflows, offset by $276,470 in financing including $374,000 from a shareholder note, leaving total debt at $1,918,350 due in 2025. No free cash flow disclosed in the 10-Q. Shares outstanding ballooned to 164 million. Losses mount without sales.
AAWH
Ascend Wellness Holdings, Inc.
0.80+0.05
BUDZ
WEED, Inc.
0.04+0.00
CANB
CAN B CORP.
0.02+0.00
CBDL
CBD Life Sciences Inc.
0.00+0.00
CHUC
Charlie's Holdings, Inc.
0.27-0.01
CWBHF
Charlotte's Web Holdings Inc.
0.16-0.00
GRAM
GOLD FLORA CORP.
0.00+0.00
RLX
RLX Technology Inc.
2.39-0.03
TOBAF
TAAT Global Alternatives Inc.
0.09+0.02
YCBD
cbdMD, Inc.
0.95-0.08